Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

Spread the loveIn a groundbreaking development that has electrified the medical community, researchers have announced the ...

Dec. 23, 2024 — A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta plaque precursors in a ...

Share on Pinterest Scientists are looking to develop a medical device that could ‘listen’ to signs of Alzheimer’s. Image ... early on in the disease course — as treatments are developed ...

"In people with progressive cognitive decline, the diagnosis of Alzheimer's disease requires a demonstration of amyloid and ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Alzheimer’s disease represents an almost insurmountable global health challenge, affecting millions worldwide with few treatment options available. Tiziana’s novel approach focuses on reducing ...

A new study, released today in The BMJ, shows that taxi drivers die at lower rates from Alzheimer’s disease than people ... “just because treatments haven’t really worked.” ...

“Within days, all of his cravings were gone and he was much more effective in his engagement and treatment ... Ozempic and Wegovy drugs, for Alzheimer’s disease. Another of the class of ...

Globally, approximately 139 million people are expected to have Alzheimer's disease (AD ... causes of cognitive impairment and inform treatment," said senior author W. Taylor Kimberly, MD ...